Gerhard Stoecklin

Title: Gerhard Stoecklin: Innovator in Radiofluoro-tyrosine Derivatives

Introduction

Gerhard Stoecklin is a notable inventor based in Munich, Germany. He has made significant contributions to the field of medical imaging through his innovative work on radiofluoro-tyrosine derivatives. His research has implications for the diagnosis and evaluation of protein synthesis in vivo, particularly in the context of cerebral diagnosis.

Latest Patents

Stoecklin holds a patent for "Radiofluoro-tyrosine derivatives, the preparation and use thereof." This patent focuses on the use of 2-radiohalogenotyrosine derivatives, specifically those containing radioactive halogens such as fluorine-18, bromine-75, or iodine-123. The derivatives, particularly 2-fluoro(18)-tyrosine and -methyltyrosine, are utilized for emission-tomographic measurement of protein synthesis, providing a valuable tool for tumor diagnosis through SPECT and PET imaging techniques. He has 1 patent to his name.

Career Highlights

Stoecklin's career has been marked by his association with the Kernforschungsanlage Julich Gesellschaft mit beschränkter Haftung, where he has conducted extensive research in the field of radiopharmaceuticals. His work has contributed to advancements in medical imaging technologies, enhancing the ability to diagnose and evaluate various conditions.

Collaborations

Throughout his career, Stoecklin has collaborated with esteemed colleagues such as Heinz Hubert Coenen and Peer Kling. These collaborations have further enriched his research and contributed to the development of innovative solutions in the field of medical imaging.

Conclusion

Gerhard Stoecklin's contributions to the field of radiofluoro-tyrosine derivatives have paved the way for advancements in medical imaging and tumor diagnosis. His innovative work continues to have a lasting impact on the field.